FDA Investigator Lori A Holmquist
Lori A Holmquist has inspections in 2 countries as of 31 Oct 2023. Lori A Holmquist has collaborated with a combinined 2906 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
170
Last Inspection Date:
31 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada
Co-Investigator(s):
Aaron L Morris,
Alan R Condon,
Alicia M Mozzachio,
Alois P Provost,
Alysia M Salonia,
Amber G Wardwell,
Amy C Amaro,
Anita R Michael,
Annet R Rajan,
Anthony C Warchut,
Anthony N Onianwa,
Arie C Menachem,
Barbara A Burke,
Barbara A Gullick,
Barbara J Holladay,
Bo Chi, PhD,
Bradford L Swanson,
Brenda P King,
Brenda W Uratani, PhD,
Brooke K Higgins,
Brooke K Seeman,
Burnell M Henry,
Candace Y Gomez Broughton,
Chryste D Best,
Clinton V Giustra,
Cynthia Jim, CSO,
Darin S Wiegers,
Dawn M Braswell,
Diane T Bargo,
Diane T O'brien,
Diantha M Bleau,
Donald C Obenhuber, PhD,
Donald L Lech,
Douglas A Campbell,
Douglas F Frazier,
Dr. Gang Wang, PhD,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Edward J Janik,
Elizabeth A Laudig,
Elizabeth B Griffin,
Ellen P Madigan,
Emest F Bizjak,
Emmanuel A Dimaano, Jr,
Erik W Koester,
Garry H Stewart,
George Pyramides,
George T Allen, Jr,
Gerald B Seaborn, Jr,
Gerald Mierle,
Gerard D Difiore,
Helen R Bester,
Helen Verdel,
Hill,
Jacek Cieslak, PhD,
Jaclyn N Munsch,
Jacqueline Mdiaz Albertini,
James H Tanner,
James W Whitney,
Jamie S Mathews,
Janis S Gallagher,
Jason B Prosser,
Jason D Tenney,
Jean Blackston Hill,
Jeanne F Broderick,
Jeffrey A Sincek,
Jeffrey R Alling,
John P Mistler,
John P Shelton,
John R Carlson,
John S Hartford,
Jonathan G Matrisciano,
Jose R Hernandez,
Joyce A Kellett,
Julie D Bringger,
Kalavati Suvarna, PhD,
Kathleen E Mcafoose,
Kenneth L Smalls,
Kenneth M Gordon,
Kenneth Nieves,
Kent A Conforti,
L Norwood,
Lauren N Barber,
Laurie B Frazier,
Laurie Graham,
Lawrence J Stringer,
LCDR Debra Emerson,
LCDR Wilfred A Darang,
Linda Thai,
Lorayne A Mcguinness,
Lori A Holquist,
Lori S Lawless,
Lorraine L Chavis,
Louis Christy,
Lynette P Salisbury,
M Patriciaurphy Murphy,
M Pedgen,
Maricelys Mercado,
Mariza M Jafary,
Marlene G Swider,
Marlene L Davis,
Mary Jeanet Mcgarry,
Mary P Murphy,
Matthew C Watson,
Matthew M Henciak,
Maxim,
Megan A Haggerty,
Melissa J Garcia,
Merideth K Rose,
Michael J Leal,
Michael P Mcpartlin,
Michael R Goga,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Mpris Inspector,
Nicholas J Scire,
Normica G Facey,
Obinna R Echeozo,
Pamela L Ogonowski,
Pankaj H Amin,
Patricia Fhughes Troost,
Patrick C Klotzbuecher,
Paul P Geraci,
Paula A Trost,
Paula M Laplant,
Pete Amin (Pankaj),
Peter R Lenahan,
Prabhu P Raju,
Ramon E Martinez,
Ranjani Prabhakara,
Rashmi Rawat, PhD,
Rebecca A Coleman,
Rebecca Rodriguez,
Richard F Hapke,
Richard G Fochesato,
Richard J Bashay,
Robert D Ogan,
Robert E Davis,
Robert E Teel,
Robert J Martin,
Robert Mo Brien,
Robert W Fisher,
Rose M Ashley,
Scott R Nichols, PhD,
Sean R Marcsisin,
Stacey S Degarmo,
State Agency,
Stephanie Mangigian, MS/OSH, RN,
Susan M Miller,
Suzanne M Healy,
Suzanne M Muchene,
Tania E Vizcaino,
Terry C Kimball,
Thomas H Jenkins,
Tiffani D Wilson,
Vesna V Stanoyevitch,
Walter L Fava,
Wanda Y Fields,
Wanda Y Honeyblue,
Wayne E Seifert,
Wella Wang,
Yvonne C Mcknight
Lori A Holmquist's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2001 | FDA 483 Response | Bindley Western Drug Co. - Form 483R, 2001-02-22 |
June, 2003 | FDA 483 | Coral Blood Services, Inc. - Form 483, 2003-06-23 |
March, 2000 | FDA 483 | Actavis Mid-Atlantic, LLC. - Form 483, 2000-03-15 |
September, 2002 | EIR | Lincare Inc. - EIR, 2002-09-04 |
March, 2001 | FDA 483 | Dr. Sidney R. Block, M.D. Clinical Investigator - Form 483, 2001-03-27 |
March, 2001 | EIR | Dr. Sidney R. Block, M.D. Clinical Investigator - EIR, 2001-04-10 |
June, 2001 | FDA 483 | Lonza Biologics, Inc. - Form 483, 2001-06-08 |
March, 2000 | EIR | Actavis Mid-Atlantic, LLC. - EIR, 2000-03-15 |
February, 2001 | FDA 483 | Bindley Western Drug Co. - Form 483, 2001-02-16 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more